BEATW
HeartBeam, Inc.
NasdaqCMUSDEQUITY
DELAYED
Last price
0.02
▲ 0.00 (35.14%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.01
Day high
0.01
Day low
0.01
Volume
1.04K
Market cap
—
P/E (TTM)
—
52W range
0.01 – 0.01
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BEATW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $13.45M | $11.05M | $6.80M | $5.68M | +21.7% |
| Selling, general & admin | $7.69M | $8.84M | $8.52M | $7.35M | -13.0% |
| Total operating expense | $21.14M | $19.89M | $15.31M | $13.03M | +6.3% |
| Operating income | -$21.14M | -$19.89M | -$15.31M | -$13.03M | -6.3% |
| Net interest income | $122.00K | $446.00K | $675.00K | $66.00K | -72.6% |
| Pre-tax income | -$21.02M | -$19.45M | -$14.64M | -$12.96M | -8.1% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$21.02M | -$19.45M | -$14.64M | -$12.96M | -8.1% |
| Net income to common | -$21.02M | -$19.45M | -$14.64M | -$12.96M | -8.1% |
| EBIT | -$21.14M | -$19.89M | -$15.31M | -$13.03M | -6.3% |
| EBITDA | -$21.10M | -$19.88M | -$15.31M | -$13.03M | -6.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.38M | $2.38M | $16.19M | $3.59M | +84.3% |
| Cash & short-term investments | $4.38M | $2.38M | $16.19M | $3.59M | +84.3% |
| Inventory | $103.00K | $0 | — | — | — |
| Total current assets | $4.68M | $2.77M | $16.82M | $4.04M | +69.1% |
| Property, plant & equipment | $1.10M | $450.00K | $256.00K | $0 | +144.9% |
| Total assets | $5.84M | $3.28M | $17.13M | $4.04M | +78.4% |
| Total current liabilities | $3.24M | $1.62M | $1.19M | $1.67M | +99.8% |
| Total liabilities | $3.24M | $1.62M | $1.19M | $1.67M | +99.8% |
| Retained earnings | -$77.29M | -$56.27M | -$36.83M | -$22.19M | -37.3% |
| Shareholder equity | $2.60M | $1.65M | $15.94M | $2.37M | +57.4% |
| Working capital | $1.45M | $1.15M | $15.63M | $2.37M | +25.9% |
| Net tangible assets | $2.60M | $1.65M | $15.94M | $2.37M | +57.4% |
| Shares issued | 40.12M | 26.96M | 26.33M | 8.01M | +48.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$21.02M | -$19.45M | -$14.64M | -$12.96M | -8.1% |
| Depreciation & amortisation | $40.00K | $7.00K | $0 | — | +471.4% |
| Stock-based compensation | $5.15M | $4.30M | $3.21M | $1.12M | +19.7% |
| Change in working capital | $1.61M | $671.00K | -$662.00K | $1.89M | +140.5% |
| Operating cash flow | -$13.99M | -$14.47M | -$12.09M | -$9.95M | +3.3% |
| Capital expenditure | -$600.00K | -$201.00K | -$256.00K | — | -198.5% |
| Investing cash flow | -$600.00K | -$201.00K | -$256.00K | $0 | -198.5% |
| Financing cash flow | $16.59M | $866.00K | $24.99M | $350.00K | +1,815.8% |
| Free cash flow | -$14.59M | -$14.67M | -$12.35M | -$9.95M | +0.6% |
| End cash position | $4.44M | $2.43M | $16.24M | $3.59M | +82.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $2.37M | $3.35M | $3.28M | $3.33M | $3.49M | -29.3% |
| Selling, general & admin | $2.35M | $1.96M | $2.01M | $1.71M | $2.01M | +19.9% |
| Total operating expense | $4.72M | $5.31M | $5.29M | $5.04M | $5.50M | -11.2% |
| Operating income | -$4.72M | -$5.31M | -$5.29M | -$5.04M | -$5.50M | +11.2% |
| Net interest income | $16.00K | $5.00K | $36.00K | $63.00K | $20.00K | +220.0% |
| Pre-tax income | -$4.70M | -$5.30M | -$5.25M | -$4.97M | -$5.48M | +11.4% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$4.70M | -$5.30M | -$5.25M | -$4.97M | -$5.48M | +11.4% |
| Net income to common | -$4.70M | -$5.30M | -$5.25M | -$4.97M | -$5.48M | +11.4% |
| EBIT | -$4.72M | -$5.31M | -$5.29M | -$5.04M | -$5.50M | +11.2% |
| EBITDA | -$4.69M | -$5.29M | -$5.28M | -$5.03M | -$5.50M | +11.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.04M | $4.38M | $1.86M | $3.26M | $4.39M | — | -53.4% |
| Cash & short-term investments | $2.04M | $4.38M | $1.86M | $5.05M | $8.15M | — | -53.4% |
| Inventory | $133.00K | $103.00K | — | — | — | $0 | +29.1% |
| Total current assets | $2.44M | $4.68M | $2.13M | $5.36M | $8.61M | — | -48.0% |
| Property, plant & equipment | $1.44M | $1.10M | $694.00K | $564.00K | $443.00K | — | +30.5% |
| Total assets | $3.93M | $5.84M | $2.88M | $5.98M | $9.11M | — | -32.8% |
| Total current liabilities | $3.29M | $3.24M | $2.47M | $1.80M | $1.58M | — | +1.7% |
| Total liabilities | $3.29M | $3.24M | $2.47M | $1.80M | $1.58M | — | +1.7% |
| Retained earnings | -$81.99M | -$77.29M | -$71.99M | -$66.73M | -$61.76M | — | -6.1% |
| Shareholder equity | $635.00K | $2.60M | $406.00K | $4.18M | $7.53M | — | -75.6% |
| Working capital | -$859.00K | $1.45M | -$344.00K | $3.56M | $7.03M | — | -159.4% |
| Net tangible assets | $635.00K | $2.60M | $406.00K | $4.18M | $7.53M | — | -75.6% |
| Shares issued | 41.13M | 40.12M | 34.34M | 34.02M | 33.73M | — | +2.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$4.70M | -$5.30M | -$5.25M | -$4.97M | -$5.48M | +11.4% |
| Depreciation & amortisation | $24.00K | $17.00K | $8.00K | $8.00K | $7.00K | +41.2% |
| Stock-based compensation | $1.22M | $1.43M | $1.43M | $1.18M | $1.11M | -14.7% |
| Change in working capital | -$151.00K | $726.00K | $653.00K | $344.00K | -$109.00K | -120.8% |
| Operating cash flow | -$3.61M | -$2.91M | -$3.16M | -$3.44M | -$4.48M | -24.2% |
| Capital expenditure | -$246.00K | -$416.00K | -$82.00K | — | — | +40.9% |
| Investing cash flow | -$246.00K | -$416.00K | $1.72M | $1.86M | -$3.76M | +40.9% |
| Financing cash flow | $1.51M | $5.85M | $45.00K | $450.00K | $10.25M | -74.1% |
| Free cash flow | -$3.86M | -$3.32M | -$3.24M | -$3.55M | -$4.48M | -16.1% |
| End cash position | $2.10M | $4.44M | $1.91M | $3.31M | $4.45M | -52.8% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $131.25K | 0.0% |
| Next quarter | — | — | $287.50K | 0.0% |
| Current year | — | — | $448.75K | 0.0% |
| Next year | — | — | $4.84M | +978.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
—
5Y monthly, from filing
Headlines
HeartBeam, Inc. Q2 2026 Earnings Call Summary
Moby · 10d ago
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ...
GuruFocus.com · 10d ago
HeartBeam Reports Second Quarter 2026 Results
Business Wire · 10d ago
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For
GuruFocus.com · 12d ago
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
Business Wire · 25d ago
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
Business Wire · 41d ago
HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital
NewMediaWire · 53d ago
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
Business Wire · 54d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.